MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorShengjing Hospital
About this trial
How to construct a non-invasive, accurate, and convenient method to evaluate the severity of liver fibrosis (LF) is an important general problem in the management of patients with chronic hepatitis B (CHB). We plan to investigate the ability of magnetic resonance elastography (MRE) to grade fibrosis in chronic hepatitis B and apply to clinical longitudinal follow-up.
Eligibility criteria
Qualifiers
Age ≥ 18 years old
Confirmed CHB (laboratory, imaging and clinical tests)
MRE within 6 months before and after liver biopsy
Treatment-naïve
Disqualifiers
Patients with liver malignant tumor
Chronic hepatitis due to other causes (such as alcoholic hepatitis)
CHB combined with hepatitis C, hepatitis D, or HIV
Patients with biliary tract diseases
Trial design
Treatments tested in this trial
- MRE
- Liver biopsy
Treatment groups
600 Participants
are divided into 2 treatment groupsLocations
1Shengjing Hospital210000, ShenyangLiaoning, China
Sponsors and collaborators
Shengjing Hospital
Lead sponsor
Source ClinicalTrials.gov